DXCM - Why DexCom Stock Is Rising During Monday's Session | Benzinga
DexCom, Inc. (NASDAQ: DXCM) shares are trading higher by 3.75% to $79.05 Thursday afternoon. Leerink Partners initiated coverage on the stock with an Outperform rating and a $110 price target.
DexCom is otherwise trading lower in recent sessions following the FDA's announcement of the establishment of a Digital Health Advisory Committee. The stock has also been under pressure in 2023, falling some 31% on a year-to-date basis, amid the popularity of weight loss drugs.
What Happened?
The FDA has created a Digital Health Advisory Committee with ...